•
Dec 31, 2022

IGM Biosciences Q4 2022 Earnings Report

Total Revenue
$372K
EPS
-$1.19
Previous year: -$1.5
-20.7%
Cash and Equivalents
$121M
Previous year: $133M
-9.1%
Free Cash Flow
-$40.6M
Previous year: -$36.7M
+10.6%
Total Assets
$513M
Previous year: $298M
+72.2%

IGM Biosciences

IGM Biosciences